S SoftMaxx AI
Peptides · Evidence-graded guide

Peptides for looksmaxxing: what the evidence actually shows

Peptides sold for looks, tiered by human evidence; we found none that measured attractiveness. Citations checked against PubMed and regulator records.

Written by SoftMaxx AI editorial · Citations checked against PubMed and regulator records · Updated 2026-10-03 · Not medically reviewed · How we grade evidence

SoftMaxx AI sells no peptides and takes no vendor money.

The verdict · strongest evidence No supporting study

No supporting study We found no study of a peptide sold for looks that measured facial attractiveness, facial proportions or the jaw in adults. Growth-hormone therapy in children with growth disorders has been studied for facial ratios and jaw growth (reported as preliminary trends); several topical peptide trials measured facial wrinkles. So most looksmaxxing claims borrow from some other outcome.[1][2][3][4]

The tier describes evidence that a peptide sold for looks changes adult face shape or attractiveness (we found none); stronger evidence here includes, among others, weight [5], wrinkle [2] [3], collagen [6] [7] [8] and MK-677 trials [9] [10], acromegaly [11] and drug labels [12] [13].

The verdict

SoftMaxx AI reviewed 74 entries (peptides, blends and peptide-adjacent compounds) and every paper we could verify on PubMed. We found no study of a peptide sold for looks that measured facial attractiveness, facial proportions or the jaw as an outcome. Growth-hormone therapy in children, a protein hormone rather than a looks peptide, has measured facial ratios and jaw growth, reported as preliminary trends [1]. The closest for looks peptides are topical trials that measured facial wrinkles [2][3].

So this page ranks peptides by how much human evidence exists, not by how good they are said to look. A high tier means more human evidence exists for some outcome. It never means a better face.

The tiers, by evidence

PeptideWhat people want from itBest human evidenceTier
Semaglutide, tirzepatideLeaner faceLarge trials for weight; none we found for the face1. Approved, for other conditions [5] [12] [13]
Oral collagen peptidesSkinMany small trials; effect absent in trials without drug-company funding2. Human trials, contested [6] [8]
Matrixyl (pal-KTTKS), palmitoyl pentapeptide-4, argirelineFewer fine linesA few small, short trials2. Human trials, small [2] [4] [3]
GHK-Cu (on the skin)Firmer skinFew, small clinical studies3. Tiny human data [17] [18]
BPC-157Skin, recoveryFive small clinical studies per FDA, two placebo-controlled; none on skin3. Tiny human data [19]
Melanotan IITanA 1996 pilot in 3 men, then case reports3. Tiny human data, documented harms [20] [21] [22]
TB-500, KPVRecovery, calmer skinFDA found no human exposure data4. Animal or cell only [23] [24] [25] [26] [27]
GLOW, KLOW, "Wolverine" blendsGlow, recoveryWe found no human study of GLOW or KLOW. For BPC-157 with TB-500, the Wolverine pair as sellers describe it, we found one rat study, a retrospective chart review in which 4 knee-pain patients got BPC-157 with thymosin-beta-4 (TB4), and one FDA adverse-event report on a BPC-157 and TB-500 product; we found no controlled human study of the pair5. None found (GLOW, KLOW); 3. Tiny human data (the Wolverine pair) [25] [28] [19]

The sections below give the sources for each row.

Injected "glow" and recovery peptides: almost no human data

Health Canada lists BPC-157, TB-500, KPV and GHK-Cu among unauthorized injectable peptides it has seized, and says such products are often promoted online, including for injury recovery and athletic performance [32].

Their human record runs from five small clinical studies (BPC-157) to no human exposure data at all (TB-500, KPV), per FDA [19] [23] [24]. FDA's briefing lists no human study of BPC-157 on skin [19]. One of the three reports for BPC-157 in FDA's drug adverse-event database (FAERS), on a product that also contained TB-500, was a skin reaction [19]; FDA's TB-500 briefing notes two more reports on blended TB-500 and BPC-157 in its food and supplement system, with no safety assessment [23]. The full breakdown is on the GLOW and KLOW pages.

Melanotan II: the tanning peptide with documented harms

Melanotan II is unlicensed [33], and we found no FDA-approved product containing it in Drugs@FDA [34]. The earliest human study we found was a 1996 pilot in 3 men [20].

Since then, the reports we found are mostly case reports of harm [21] [22] [35] [33]. Vials sold illegally online held less drug than labelled, and vials from two of three shops held unknown impurities [36].

MK-677, growth hormone and follistatin: the jaw myths

We found no trial showing that growth-hormone drugs give adults a bigger jaw.

In adults, jaw and facial bone growth from excess growth hormone is documented in acromegaly, a chronic disease whose signs progress slowly [11]. Claims about hard mewing deserve the same caution. In a lab analysis of 17 black-market "follistatin 344" products, only 9 contained follistatin [38]. The jawline page covers this in full.

GLP-1 drugs and "Ozempic face"

Semaglutide and tirzepatide are FDA-approved drugs [39]: semaglutide as Ozempic for diabetes [15] and as Wegovy to reduce excess body weight [12]. Your prescriber sets your dose; the Wegovy label is on DailyMed [12].

Rapid weight loss on semaglutide can deplete facial volume and fat [15]. We found no trial that tested the face directly. Hair loss is listed as a side effect on the Wegovy label [12].

Oral collagen: pooled gains, funding questions

Oral collagen is used as a supplement [6]. Meta-analyses have pooled 19 to 26 randomized skin trials of it [6][7].

The catch is who paid for them. In a 2025 meta-analysis, the benefit was absent in trials without pharmaceutical-company funding and in high-quality trials [8].

Topical peptides: small, short trials

Trials of peptide creams and serums measured fine lines and wrinkles over weeks, not face shape [2][3]. The skin guide ranks them one by one.

Further reading

For the broader idea, see what softmaxxing is and looksmaxxing vs softmaxxing.

Doses used in studies (not a recommendation)

Each row comes from the cited source: a study dose, a safety-review limit or a registered trial's planned dose, as labelled. Where the abstract states no amount, the row says so. They are a record of what was reported, not dosing instructions, and nothing here says what you should take.

Studied inRouteAmount reportedHow oftenHow longnSource
humanoral2.5 g collagen peptides Study doseonce daily8 weeks114[40] Women aged 45–65; eye-wrinkle trial.
humantopical (split-face moisturizer)3 ppm pal-KTTKS (palmitoyl pentapeptide) Study dosenot stated in the abstract12 weeks93[2] Women aged 35–55 with photoaged facial skin.

Side effects and risks

Regulatory status (checked 2026-10-01 to 2026-10-03)

Report a side effect

If something went wrong after using a health product, tell a clinician. Report side effects to:

Common questions

What is the best peptide for the face?

We found none shown to change face shape or the jaw, and no study of a peptide sold for looks that measured facial attractiveness, facial proportions or the jaw. The closest data are small topical trials that measured facial wrinkles: 4 weeks for argireline (60 people) and 12 weeks for palmitoyl pentapeptide (93 women).[2][3]

Will semaglutide make my face slimmer or give me a jawline?

We found no trial that measured the face. A facial plastic surgery review says rapid weight loss on semaglutide can lead to "Ozempic face", where facial volume and fat are depleted [15]. Semaglutide is a prescription drug; your prescriber decides if it fits you.[15][16]

Can MK-677 make you taller or grow your jaw?

No trial we found supports it, and none measured facial bones. In a 2-year trial in adults aged 60 to 81 it raised blood sugar, did not reduce body fat and caused mild, transient leg swelling.[9]

Does Melanotan 2 cause cancer or new moles?

New moles and darkening of existing moles are documented in a Melanotan II case report, and a melanoma has been reported in a user who also used sunbeds, so cause is not proven. Two more reports, for which PubMed lists no abstract, are titled for melanotan without naming which. It is unlicensed, and we found no FDA-approved product containing it in Drugs@FDA.[21][22][35][33] Source: FDA: Drugs@FDA search: melanotan-ii — no approved product found

Does collagen powder actually work for skin, or is it just digested?

Some collagen fragments do reach the blood. Pooled trials show gains in hydration and elasticity, but in a 2025 meta-analysis those gains were absent in trials without pharmaceutical-company funding and in high-quality trials.[42][8]

References

References to papers were matched to their PubMed or DOI records. Regulator, label and registry pages were fetched and saved by us; each status line under Regulatory status gives the date its source was captured. "Verified" means the paper exists and is the one named; what it supports is stated next to each claim.

  1. Effects of growth hormone therapy on facial anthropometric features in children with growth disorders: a cohort study. Ann Med Surg (Lond) (2026). PubMed 42583639 DOI
  2. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci (2005). PubMed 18492182 DOI
  3. The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. Am J Clin Dermatol (2013). PubMed 23417317 DOI
  4. Double-blind, Randomized Trial on the Effectiveness of Acetylhexapeptide-3 Cream and Palmitoyl Pentapeptide-4 Cream for Crow's Feet. J Clin Aesthet Dermatol (2023). PubMed 36909866
  5. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med (2021). PubMed 33567185 DOI
  6. Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis. Int J Dermatol (2021). PubMed 33742704 DOI
  7. Effects of Oral Collagen for Skin Anti-Aging: A Systematic Review and Meta-Analysis. Nutrients (2023). PubMed 37432180 DOI
  8. Effects of Collagen Supplements on Skin Aging: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Med (2025). PubMed 40324552 DOI
  9. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med (2008). PubMed 18981485 DOI
  10. MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: a multicenter, randomized, placebo-controlled phase IIb study. Arch Gerontol Geriatr (2011). PubMed 21067829 DOI
  11. Oral Manifestations and Maxillo-Facial Features in the Acromegalic Patient: A Literature Review. J Clin Med (2022). PubMed 35207363 DOI
  12. WEGOVY (semaglutide) injection; WEGOVY (semaglutide) tablets — Prescribing Information DailyMed (2026). Source
  13. ZEPBOUND (tirzepatide) injection — Prescribing Information DailyMed (2026). Source
  14. Public Interest in Acetyl Hexapeptide-8: Longitudinal Analysis. JMIR Dermatol (2024). PubMed 38376906 DOI
  15. Implications of Ozempic and Other Semaglutide Medications for Facial Plastic Surgeons. Facial Plast Surg (2023). PubMed 37541662 DOI
  16. Natural Weight Loss or "Ozempic Face": Demystifying A Social Media Phenomenon. J Drugs Dermatol (2024). PubMed 38206146 DOI
  17. Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective. Bioimpacts (2025). PubMed 39963574 DOI
  18. A Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper Complex) in Topical Microneedle Delivery: A Case for Expanded Clinical Trials. Arch Intern Med Res (2026). PubMed 42787770 DOI
  19. July 23-24, 2026, Meeting of the Pharmacy Compounding Advisory Committee – FDA Briefing Document for BPC-157-Related Bulk Drug Substances (BPC-157 (free base) and BPC-157 acetate) (2026). Source
  20. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sci (1996). PubMed 8637402 DOI
  21. Eruptive melanocytic naevi following melanotan injection. Br J Dermatol (2009). PubMed 19575725 DOI
  22. Eruptive naevi and darkening of pre-existing naevi 24 h after a single mono-dose injection of melanotan II. Eur J Dermatol (2014). PubMed 24334249 DOI
  23. July 23-24, 2026, Meeting of the Pharmacy Compounding Advisory Committee – FDA Briefing Document for TB-500-Related Bulk Drug Substances (TB-500 (free base) and TB-500 acetate) (2026). Source
  24. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks fda.gov (2026). Source
  25. Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study. Joint diseases and related surgery (2026). PubMed 42542926 DOI
  26. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology (2008). PubMed 18061177 DOI
  27. alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells. J Invest Dermatol (2004). PubMed 15102092 DOI
  28. Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain. Alternative therapies in health and medicine (2021). PubMed 34324435
  29. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS journal : the musculoskeletal journal of Hospital for Special Surgery (2025). PubMed 40756949 DOI
  30. Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study. Alternative therapies in health and medicine (2024). PubMed 39325560
  31. Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. Alternative therapies in health and medicine (2025). PubMed 40131143
  32. Think twice before injecting peptides bought online: unauthorized products can seriously harm you (Health Canada advisory; lists KPV) Recalls and safety alerts, Government of Canada (2026). Source
  33. Melanoma associated with the use of melanotan-II. Dermatology (2014). PubMed 24355990 DOI
  34. Drugs@FDA search: melanotan-ii — no approved product found (2026-10-01) Drugs@FDA (openFDA) (2026). Source
  35. Melanotan-associated melanoma. Br J Dermatol (2011). PubMed 21564053 DOI
  36. Identification and characterization by LC-UV-MS/MS of melanotan II skin-tanning products sold illegally on the Internet. Drug Test Anal (2015). PubMed 24771717 DOI
  37. An overview of benefits and risks of chronic melanocortin-1 receptor activation. J Eur Acad Dermatol Venereol (2025). PubMed 39082868 DOI
  38. Detection of black market follistatin 344. Drug testing and analysis (2019). PubMed 31758732 DOI
  39. Dangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs. Mo Med (2026). PubMed 42757290
  40. Oral intake of specific bioactive collagen peptides reduces skin wrinkles and increases dermal matrix synthesis. Skin Pharmacol Physiol (2014). PubMed 24401291 DOI
  41. Investigating the effects of Argireline in a skin serum containing hyaluronic acids on skin surface wrinkles using the Visia® Complexion Analysis camera system for objective skin analysis. GMS Interdiscip Plast Reconstr Surg DGPW (2023). PubMed 38024099 DOI
  42. Identification of food-derived collagen peptides in human blood after oral ingestion of gelatin hydrolysates. J Agric Food Chem (2005). PubMed 16076145 DOI

Written by SoftMaxx AI editorial · Citations checked against PubMed and regulator records · Updated 2026-10-03 · Not medically reviewed. Editorial standards · Evidence grading and update log.

Keep reading